The BD&L Summit for Life Sciences – The BD&L Summit for Life Sciences
The growing emergence of biotech companies and specialized knowledge base has lead to a shift in strategic focus for life science companies. Even though R&D spend is on the rise, companies still look to external targets as a means of supplementing pipelines and bolstering their product portfolios. The need to expand the reach of R&D programs has driven major new investments in co-development, licensing, acquisitions and strategic alliances, as companies look to gain access to new sources of innovation.
With so many factors affecting the potential value of a transaction, it is essential for life science organizations to effectively assess the risks associated with a deal, explore innovative models and deal structures for working with strategic partners, collaborate with cross-functional partners to realize business synergies, and develop processes for the efficient and optimal negotiation and closing of a transaction.
The BD&L Summit for Life Sciences will provide attendees with valuable insights and actionable strategies from cross-functional business development teams in successfully managing alliances, licensing agreements, and M&A deals. This event serves as an educational platform for industry experts responsible for R&D, search and evaluation, external innovation, legal/IP, portfolio management, alliance management, business development and licensing, and will feature leadership representation from biotechs, mid-sized and large pharmaceutical, medical device and diagnostics companies.
MEET OUR 2019 ADVISORY BOARD
Senior Director, Lilly Research Labs – Due Diligence
Vice President, Head of Business Development Operations, Business Development and Licensing
Martin Picard, Ph.D.
Head, Search, Evaluation and Due Diligence, Biopharma R&D/External Innovation
Marc Schwabish, Ph.D.
Senior Vice President, Business Development and U.S. Operations
Who Should Attend:
This conference is designed for representatives from pharmaceutical, medical device and biotechnology companies with responsibilities in the following areas:
- Business Development
- Mergers and Acquisitions
- Strategic Alliance/Alliance Management
- Intellectual Property and Patent Counsel
- Search and Evaluation
- Due Diligence
- External Innovation
- Portfolio Management
- Scientific Assessment
- General Counsel/Corporate Counsel
- Legal and Regulatory Compliance
- Regulatory Affairs
- Research and Development
- Clinical Medicine
- Clinical Operations
- Lifecycle Management
This conference is also of interest to:
- Investment Banks
- Private Equity Firms
- Venture Capitalists
- Data Room Providers
- Due Diligence Consultants
- Law Firms
- Clinical Affairs and CRO Partners
- Regulatory Affairs and Compliance Partners